Amgen reports soft 4Q17 earnings, mixed 2018 guidance

Amgen Inc. (NASDAQ:AMGN) reported 4Q17 earnings late Thursday that were below analyst estimates and announced uneven 2018 guidance. The company slipped $3.56 to $182 in after-hours trading.

Amgen posted 4Q17 non-GAAP EPS of $2.89 on revenues of $5.8 billion, below the consensus estimates of $3.03 and $5.85 billion, respectively. ...